comparemela.com

Latest Breaking News On - Thoracoabdominal artery stent graft system - Page 1 : comparemela.com

LifeTech Scientific Corporation (1302 HK) Announces 2023 Interim Results

LifeTech Reports Steady Growth of 32 5percent in Net Profit Attributable to Owners of the Company in 2022

LifeTech Reports Steady Growth of 32 5percent in Net Profit Attributable to Owners of the Company in 2022

SHENZHEN, China, March 29, 2023 /PRNewswire/ LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results. During the year ended 31 December 2022, Lifetech achieved a revenue of approximately RMB1,097.3 million, increased by 18.6% year on year. The.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.